The Cell & Gene Therapy Drug Delivery Devices Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector’s strengths, weaknesses, opportunities, and threats, while also considering political, economic, social, technological, environmental, and legal factors. Expert reviews of competitor strategies and recent developments provide a clearer view of regional dynamics and future market trajectories, establishing a strong foundation for strategic planning and informed investment decisions.

What will be the market size of Global Cell & Gene Therapy Drug Delivery Devices Market 2030?

The Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

Download Free PDF Brochure: https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

 Who are the top companies operating in the Global Cell & Gene Therapy Drug Delivery Devices Market?

The report features prominent companies operating in the Cell & Gene Therapy Drug Delivery Devices Market and the successful strategies they have adopted. It also provides detailed insights into each company’s market share and their role in driving the industry’s growth. As per MarkNtel Advisors, top companies in Cell & Gene Therapy Drug Delivery Devices Market: Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation

What is the key factor projected to fuel growth in the Global Cell & Gene Therapy Drug Delivery Devices Market between 2025 and 2030?

Growing Occurrence of Chronic and Genetic Disorders – One of the leading drivers propelling the global cell and gene therapy drug delivery devices market is the increasing prevalence of chronic diseases, particularly cancer, diabetes, and genetic disorders. As these complex conditions become more widespread, there is a growing demand for advanced therapies that can offer targeted and effective treatment options. Cell and gene therapies have emerged as transformative solutions, and their success relies heavily on innovative drug delivery devices that ensure precise administration, optimal dosage, and improved patient outcomes. This surge in chronic disease cases not only fuels the adoption of these therapies but also accelerates the development and deployment of specialized delivery devices, thereby driving robust market growth.

 Browse Full Research Report: https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Global Cell & Gene Therapy Drug Delivery Devices Market - Segmentation Analysis

• By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML))

• By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles)

• By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis)

• By End-Users (Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospitals & Clinics) 

How does the Global Cell & Gene Therapy Drug Delivery Devices Market vary across different geography?

By Region

• North America

• South America

• Europe

• Middle East & Africa

 This Section cover detailed analysis of revenue, market share and growth rate, historical data (2020-23) and forecast (2025-2030) of the following segmentation and geography.

Inquire Before Buying, Connect with our Expertise Today: https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Comprehensive Table of Contents – Global Cell & Gene Therapy Drug Delivery Devices Market Analysis and Forecast, 2030

1. Table 1: Introduction

2. Table 2: Executive Summary

3. Table 3: Market Regulations, Policies & Standards

4. Table 4: Cell & Gene Therapy Drug Delivery Devices Market Size, Share & Scope, 2018-2028

5. Table 5: Market Trends & Developments

6. Table 6: Market Dynamics (Key Drivers, and Challenges)

7. Table 7: Market Hotspots & Opportunities

8. Table 8: Market Value Chain Analysis

9. Table 9: Market Outlook, 2018-2028

10. Table 10: Market Size & Analysis by Revenues (USD Million): 

11. Table 11: Market Size & Forecast 2018-2028 by Segmentation

12. Table 12: Market Size & Forecast 2018-2028 by Geography

13. Table 13: Key Strategic Imperatives for Success & Growth

14. Table 14: Competitor Analysis of Global Cell & Gene Therapy Drug Delivery Devices Companies

Key Benefits for Industry Participants and Stakeholders

• Insight into emerging market trends and investment opportunities

• Understanding of regional market dynamics and competitive landscapes

• Data-driven forecasts to support strategic decision-making

• Access to industry benchmarks for performance evaluation

• Identification of potential risks and growth challenges

Browse More Reports:

• Bahrain Electric Vehicle Market Research Report: Forecast (2025-2030)

• Italy Electric Scooter Market Research Report: Forecast (2025-2030)

• Saudi Arabia Protein Bar Market Research Report: Forecast (2025-2030)

• Saudi Arabia Ice Cream Market Research Report: Forecast (2025-2030)

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com